ΓΑΣΤΡΕΝΤΕΡΟΛΟΓΙΚΟ ΙΑΤΡΕΙΟ

04/08/2026

https://www.facebook.com/share/r/1Xt8KjtJrE/

01/08/2026

https://www.facebook.com/share/v/1PS7o8eZ3x/

30/07/2026

https://www.facebook.com/share/r/1LNBjRJrzu/

30/07/2026

https://www.facebook.com/share/p/1SWH7j43xZ/

Gallstones often remain silent for years, but when they become symptomatic, they can trigger sudden right upper abdominal pain, especially after fatty meals, with pain that may radiate to the right shoulder or back. While many patients never require treatment, persistent pain, fever, jaundice, or recurrent vomiting may signal acute complications that demand urgent medical evaluation. Early recognition, healthy weight management, balanced nutrition, and avoiding rapid weight loss are key strategies to reduce both the risk of stone formation and its potentially serious consequences.

24/07/2026

https://www.facebook.com/share/r/1E4aG8Nc54/

23/07/2026

https://www.facebook.com/share/v/18AaB1ejvn/

16/07/2026

https://www.facebook.com/share/r/1CW8TBDmNy/

15/07/2026

https://www.facebook.com/share/p/1TpVj4TZ1k/

Superior mesenteric artery syndrome

14/07/2026

https://www.facebook.com/share/197AhzEvJa/

For many people with chronic hepatitis B, antiviral medicines keep the virus under control but rarely remove it completely. Researchers have now discovered that a specific group of immune cells inside the liver, called CD4 positive T cells, may play a much bigger role in clearing the virus than previously believed. The study combined laboratory research with patient samples and found that these cells help organize a broader immune attack when antiviral treatment is carefully stopped in some patients. This research helps explain why a small number of people naturally clear the infection after treatment ends.

The researchers found that CD4 positive T cells detect viral proteins in the liver and release signals that activate many other immune cells. Together, these cells form organized clusters that strengthen the immune response and improve the body's ability to recognize infected liver cells. In contrast, these protective immune clusters were much weaker in people who remained chronically infected, allowing the virus to continue surviving inside liver tissue.

These findings suggest that future treatments may focus on activating CD4 positive T cells instead of targeting the virus alone. The research is an important step toward developing therapies that help the immune system achieve long lasting control or even eliminate chronic hepatitis B in more patients.


RESEARCH PAPER 📄
PMID: 42054492